AGXT and primary hyperoxaluria: Besides applications for PH1 therapy, drugs reducing hyperoxaluria by GPT overexpression might be effective also for treatment of other forms of primary hyperoxalurias (e.g., PH2 and PH3) and more common forms of secondary hyperoxaluria (Xu et al., 2013).